D-0436-2022 Class II Terminated
FDA drug recall D-0436-2022 was initiated by Edge Pharma, LLC on Dec 6, 2021 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Jun 7, 2023). Affected quantity: 74 jars.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 2, 2022
- Initiation Date
- Dec 6, 2021
- Termination Date
- Jun 7, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 74 jars
Product description
LT Topical Cream, Lidocaine/Tetracaine, 23%/7%, 60gm per jar, Multiple Dose Container for Topical Use, Edge Pharma, LLC, 856 Hercules, VT, Colchester, VT 05446, NDC 05446-1647-01
Reason for recall
CGMP Deviations
Distribution pattern
nationwide
Code information
08-2021-23@9 02-19-2022, 09-2021-07@13 03-06-2022 & 10-2021-22@5 04-20-2022.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0436-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026